Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting

Christina Ruhlmann, Jørn HerrstedtOdense University Hospital, Department of Oncology, Odense, DenmarkAbstract: Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. The knowledge of the pathogenesis and...

Full description

Bibliographic Details
Main Authors: Christina Ruhlmann, Jørn Herrstedt
Format: Article
Language:English
Published: Dove Medical Press 2009-05-01
Series:Therapeutics and Clinical Risk Management
Online Access:http://www.dovepress.com/casopitant-a-novel-nk1-receptor-antagonist-in-the-prevention-of-chemot-a3117